tiprankstipranks
Trending News
More News >
Guard Therapeutics International AB (SE:GUARD)
:GUARD
Sweden Market

Guard Therapeutics International AB (GUARD) Income Statement

Compare
0 Followers

Guard Therapeutics International AB Income Statement

Last quarter (Q2 2025), Guard Therapeutics International AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Guard Therapeutics International AB's net income was kr-32.22M. See Guard Therapeutics International AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr 0.00kr -15.00Kkr -15.00Kkr -15.00K
Operating Expenses
kr 107.74Mkr 99.91Mkr 115.07Mkr 113.63Mkr 81.28M
Depreciation and Amortization
kr 0.00kr 15.00Kkr 15.00Kkr 15.00Kkr 15.00K
EBITDA
kr -107.74Mkr -100.23Mkr -114.91Mkr -112.82Mkr -82.01M
Operating Income
kr -107.74Mkr -99.91Mkr -115.07Mkr -114.92Mkr -81.90M
Other Income/Expenses
kr -1.11Mkr 3.84Mkr 1.75Mkr 2.08Mkr -130.00K
Pretax Income
kr -108.85Mkr -96.07Mkr -113.32Mkr -112.84Mkr -82.03M
Net Income
kr -108.85Mkr -96.07Mkr -113.32Mkr -110.76Mkr -82.16M
Per Share Metrics
Basic EPS
kr -6.04kr -8.62kr -11.26kr -15.72kr -0.74
Diluted EPS
kr -6.04kr -8.62kr -11.26kr -15.72kr -0.74
Weighted Average Shares Outstanding
18.03M 11.15M 10.06M 7.05M 110.30M
Weighted Average Shares Outstanding (Diluted)
18.03M 11.15M 10.06M 7.05M 110.30M
Currency in SEK

Guard Therapeutics International AB Earnings and Revenue History